Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pieters, J.
Right arrow Articles by Hemker, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pieters, J.
Right arrow Articles by Hemker, H. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma

J Pieters, T Lindhout and HC Hemker

Department of Biochemistry, University of Limburg, Maastricht, The Netherlands.

We investigated the activation of the nonenzymatic protein cofactors factor VIII and factor V in plasma when coagulation was initiated by thromboplastin. With sensitive bioassays, we were able to measure specifically the generation of activated factor VIII and activated factor V in plasma. Our results showed that when plasma was triggered with a relatively high concentration of thromboplastin, factor VIII and factor V were completely activated at the clotting time of plasma. However, when the generation of thrombin, but not that of factor Xa, was delayed by addition of hirudin to the plasma, factor Va was generated only at the time thrombin generation overcame the hirudin inhibition. In addition, generation of factor VIIIa correlated with thrombin generation and not with factor Xa generation. Furthermore, addition of large amounts of factor Xa to hirudinized plasma did not show detectable factor VIII or factor V activation. We concluded that in plasma activated with thromboplastin the enzyme responsible for activation of factor V and factor VIII is thrombin, not factor Xa.

Volume 74, Issue 3, pp. 1021-1024, 08/15/1989
Copyright © 1989 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. L. Newell and P. J. Fay
Proteolysis at Arg740 Facilitates Subsequent Bond Cleavages during Thrombin-catalyzed Activation of Factor VIII
J. Biol. Chem., August 31, 2007; 282(35): 25367 - 25375.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Bukys, P. Y. Kim, M. E. Nesheim, and M. Kalafatis
A Control Switch for Prothrombinase: CHARACTERIZATION OF A HIRUDIN-LIKE PENTAPEPTIDE FROM THE COOH TERMINUS OF FACTOR Va HEAVY CHAIN THAT REGULATES THE RATE AND PATHWAY FOR PROTHROMBIN ACTIVATION
J. Biol. Chem., December 22, 2006; 281(51): 39194 - 39204.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Jesty and E. Beltrami
Positive Feedbacks of Coagulation: Their Role in Threshold Regulation
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2463 - 2469.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Nogami, Q. Zhou, H. Wakabayashi, and P. J. Fay
Thrombin-catalyzed activation of factor VIII with His substituted for Arg372 at the P1 site
Blood, June 1, 2005; 105(11): 4362 - 4368.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
M. Tobu, O. Iqbal, H. L. Messmore, Q. Ma, D. A. Hoppensteadt, and J. Fareed
Influence of Different Anticoagulant Agents on Fibrinopeptide A Generation
Clinical and Applied Thrombosis/Hemostasis, October 1, 2003; 9(4): 273 - 292.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. G. Mann, S. Butenas, and K. Brummel
The Dynamics of Thrombin Formation
Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 17 - 25.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. M. Monroe, M. Hoffman, and H. R. Roberts
Platelets and Thrombin Generation
Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1381 - 1389.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Butenas, K. M. Cawthern, C. van't Veer, M. E. DiLorenzo, J. B. Lock, and K. G. Mann
Antiplatelet agents in tissue factor-induced blood coagulation
Blood, April 15, 2001; 97(8): 2314 - 2322.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. R. Abendschein, P. K. Baum, P. Verhallen, P. R. Eisenberg, M. E. Sullivan, and D. R. Light
A Novel Synthetic Inhibitor of Factor Xa Decreases Early Reocclusion and Improves 24-h Patency after Coronary Fibrinolysis in Dogs
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 567 - 572.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. A. Merlini, D. Ardissino, R. D. Rosenberg, E. Colombi, P. Agricola, L. Oltrona, F. Ottani, M. Galvani, K. A. Bauer, B. Bottasso, et al.
In Vivo Thrombin Generation and Activity During and After Intravenous Infusion of Heparin or Recombinant Hirudin in Patients With Unstable Angina Pectoris
Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2162 - 2166.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. H. M. Senden, T. M. A. A. Jeunhomme, J. W. M. Heemskerk, R. Wagenvoord, C. van't Veer, H. C. Hemker, and W. A. Buurman
Factor Xa Induces Cytokine Production and Expression of Adhesion Molecules by Human Umbilical Vein Endothelial Cells
J. Immunol., October 15, 1998; 161(8): 4318 - 4324.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. M. Cawthern, C. van `t Veer, J. B. Lock, M. E. DiLorenzo, R. F. Branda, and K. G. Mann
Blood Coagulation in Hemophilia A and Hemophilia C
Blood, June 15, 1998; 91(12): 4581 - 4592.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. A. Merlini, D. Ardissino, K. A. Bauer, L. Oltrona, A. Pezzano, B. Bottasso, R. D. Rosenberg, and P. M. Mannucci
Persistent Thrombin Generation During Heparin Therapy in Patients With Acute Coronary Syndromes
Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1325 - 1330.
[Abstract] [Full Text]


Home page
CirculationHome page
N. A. Prager, D. R. Abendschein, C. R. McKenzie, and P. R. Eisenberg
Role of Thrombin Compared With Factor Xa in the Procoagulant Activity of Whole Blood Clots
Circulation, August 15, 1995; 92(4): 962 - 967.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. M. Regan and P. J. Fay
Cleavage of Factor VIII Light Chain Is Required for Maximal Generation of Factor VIIIa Activity
J. Biol. Chem., April 14, 1995; 270(15): 8546 - 8552.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1989 by American Society of Hematology         Online ISSN: 1528-0020